BIO-key International Joins AWS ISV Accelerate Program to Elevate Biometric Security Solutions on AWS
07 Setembro 2023 - 9:57AM
BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider
of workforce and customer identity and access management (IAM)
solutions featuring Identity-Bound Biometrics (IBB), is proud to
announce its acceptance into the Amazon Web Services (AWS)
Independent Software Vendor (ISV) Accelerate Program, a co-sell
program for AWS Partners that provide software solutions that run
on or integrate with AWS. Having joined the AWS Partner Network in
June of 2022, acceptance to the Accelerate Program marks a
significant milestone in BIO-key's journey to provide advanced
biometric security solutions on AWS.
As a member of this program, BIO-key will access
a wide range of resources and benefits, including technical
enablement, go-to-market support, and co-selling opportunities,
allowing the company to deliver enhanced security offerings to AWS
customers, globally.
BIO-key's biometric authentication solutions
offer unparalleled security and convenience, leveraging unique
biometric identifiers such as fingerprints, faces, palm scans, and
more. With support from AWS, BIO-key aims to make its cutting-edge
biometric technology easily accessible to businesses of all sizes,
from startups to enterprises, seeking to fortify their digital
environments against ever-evolving cybersecurity threats.
"BIO-key is thrilled to be accepted into the AWS
ISV Accelerate Program, which validates the strength of our
biometric authentication solutions and our commitment to innovation
in the field of cybersecurity," said Galen Rodgers, VP of Sales
& Channel, BIO-key International. "Our work with AWS will help
us to further enhance the security posture of organizations using
AWS, providing a frictionless yet robust authentication experience
for users."
As BIO-key works with AWS to continue expanding
its reach and capabilities, both companies are committed to driving
innovation and raising the bar for security solutions in the cloud
computing landscape.
To learn more about the AWS ISV Accelerate program,
please visit
https://aws.amazon.com/partners/programs/isv-accelerate/.
About BIO-key International,
Inc. (www.BIO-key.com)BIO-key is revolutionizing
authentication and cybersecurity with biometric-centric,
multi-factor identity and access management (IAM) software managing
millions of users. Its cloud-based PortalGuard IAM solution
provides cost-effective, easy-to-deploy, convenient, and secure
access to devices, information, applications, and high-value
transactions. BIO-key's patented software and hardware solutions,
with industry-leading Identity-Bound Biometric (IBB) capabilities,
enable large-scale Identity-as-a-Service (IDaaS) solutions and
customized on-premises solutions.
BIO-key Safe Harbor Statement
All statements contained in this press release
other than statements of historical facts are "forward-looking
statements" as defined in the Private Securities Litigation Reform
Act of 1995 (the "Act"). The words "estimate," "project,"
"intends," "expects," "anticipates," "believes" and similar
expressions are intended to identify forward-looking statements.
Such forward-looking statements are made based on management's
beliefs, as well as assumptions made by, and information currently
available to, management pursuant to the "safe-harbor" provisions
of the Act. These statements are not guarantees of future
performance or events and are subject to risks and uncertainties
that may cause actual results to differ materially from those
included within or implied by such forward-looking statements.
These risks and uncertainties include, without limitation, our
history of losses and limited revenue; our ability to raise
additional capital; our ability to continue as a going concern; our
ability to protect our intellectual property; changes in business
conditions; changes in our sales strategy and product development
plans; changes in the marketplace; continued services of our
executive management team; security breaches; competition in the
biometric technology industry; market acceptance of biometric
products generally and our products under development; our ability
to execute and deliver on contracts in Africa; our ability to
expand into Asia, Africa and other foreign markets; our ability to
integrate the operations and personnel of Swivel Secure into our
business; fluctuations in foreign currency exchange
rates; delays in the development of products and statements of
assumption underlying any of the foregoing as well as other factors
set forth under the caption "Risk Factors" in our Annual Report on
Form 10-K for the year ended December 31, 2022 and other filings
with the Securities and Exchange Commission. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which speak only as of the date made. Except as required by law, we
undertake no obligation to disclose any revision to these
forward-looking statements whether as a result of new information,
future events, or otherwise.
Engage with BIO-key:
Facebook –
Corporate: |
https://www.facebook.com/BIOkeyInternational/ |
LinkedIn – Corporate: |
https://www.linkedin.com/company/bio-key-international |
Twitter – Corporate: |
@BIOkeyIntl |
Twitter – Investors: |
@BIO_keyIR |
StockTwits: |
BIO_keyIR |
|
|
Investor Contacts:
William Jones, David CollinsCatalyst
IRBKYI@catalyst-ir.com212-924-9800
BIO key (NASDAQ:BKYI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
BIO key (NASDAQ:BKYI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024